# Can FOXO4-DRI combat inflammaging in keloid fibroblasts?

Canonical source: https://retacompare.com/research/can-foxo4-dri-combat-inflammaging-in-keloid-fibroblasts

Peptide Longevity Q&A · 2025-02-24


    Research indicates that FOXO4-DRI promotes apoptosis in senescent fibroblasts associated with keloids, potentially combating the persistent senescent microenvironment that contributes to chronic inflammation. This suggests a role for FOXO4-DRI in addressing inflammaging in this context.


What the research shows

The study focuses on keloids, which are pathological scars characterized by aggressive growth and high recurrence rates. Through single-cell RNA sequencing, the researchers identified an increased proportion of pro-inflammatory and mesenchymal fibroblast subpopulations, along with elevated levels of senescent fibroblasts. The expression of senescence-associated secretory phenotype genes was also enhanced. Notably, the study revealed that keloids exhibited upregulated p53-serine15 phosphorylation (p53-pS15), which was confirmed using phosphospecific protein microarrays and western blotting techniques. In experimental models, the FOXO4-D-retro-inverso-isoform peptide (FOXO4-DRI) was shown to induce apoptosis and decrease G0/G1 phase cells in keloid organ cultures and fibroblasts, facilitating nuclear exclusion of p53-pS15.


Why it matters for longevity

This research highlights the role of senescent cells in the aging process, particularly in the context of keloids, which may serve as a model for understanding chronic inflammation and its impact on healthspan. Senescent cells can contribute to a pro-inflammatory environment, known as inflammaging, which is linked to various age-related diseases. By promoting apoptosis in these senescent fibroblasts, FOXO4-DRI may help mitigate the negative effects of chronic inflammation, potentially improving health outcomes in aging populations. This suggests that targeting cellular senescence could be a valuable strategy in enhancing longevity and quality of life.


Key findings at a glance

FOXO4-DRI induces apoptosis in senescent fibroblasts associated with keloids.

Keloids show increased levels of pro-inflammatory and mesenchymal fibroblast subpopulations.

Upregulation of p53-pS15 is identified in keloid fibroblasts.

FOXO4-DRI decreases G0/G1 phase cells in keloid organ cultures.

Research suggests FOXO4-DRI may combat the senescent microenvironment in keloids.


How FOXO4-DRI works (background)

FOXO4-DRI is a senolytic peptide that targets senescent cells, promoting their apoptosis. In the context of keloids, it appears to work by inducing the nuclear exclusion of phosphorylated p53, a protein that is often associated with cell cycle arrest and apoptosis resistance in senescent cells. By facilitating the removal of these dysfunctional cells, FOXO4-DRI may help restore tissue homeostasis and reduce inflammation, which is crucial for preventing the aggressive behavior of keloids and possibly other age-related conditions.


Safety, caveats, and what we don't yet know

While the findings indicate a promising role for FOXO4-DRI in targeting senescent cells, it is important to note that this research is in preclinical stages. The specific safety profile of FOXO4-DRI in humans has not yet been established, and further studies are needed to evaluate its long-term effects and efficacy across different populations. Additionally, the research primarily focuses on keloids, and its applicability to other forms of chronic inflammation or aging-related conditions remains to be explored.


Bottom line

FOXO4-DRI shows potential in combating the senescent microenvironment associated with keloids, which may help address chronic inflammation and its effects on aging.


Related questions

How does FOXO4-DRI influence aging processes?

Research suggests that FOXO4-DRI may help reduce the burden of senescent cells, which are implicated in aging and age-related diseases, thereby potentially enhancing overall healthspan.


Can FOXO4-DRI be used in other inflammatory conditions?

While current research focuses on keloids, the mechanism of FOXO4-DRI may have implications for other inflammatory conditions linked to cellular senescence, warranting further investigation.


What are senolytic peptides?

Senolytic peptides, like FOXO4-DRI, are compounds designed to selectively induce death in senescent cells, aiming to alleviate the negative effects of cellular senescence on health and longevity.


Source: PubMed · Commun Biol · published 2025-02-24.

## Sources

- PubMed · Commun Biol: https://pubmed.ncbi.nlm.nih.gov/39994346/